Bayesian MMRM R Package Development

Lead: Will Landau (Eli Lilly)

Objective: To develop an R package for Bayesian mixed models with repeated measures (MMRM) to support robust analysis of longitudinal clinical data.

First Name Last Name Affiliation
Andrew Bean Novartis
Christian Stock Boehringer Ingelheim
Daniel Leibovitz Independent
Kevin Kunzmann Boehringer Ingelheim
Will Landau Eli Lilly
Yoni Sidi Sanofi

To learn more about our Bayesian MMRM R package using brms, please visit